1. No Further Ebola Cases In Uganda After June Deaths: DR Congo  iAfrica.com
  2. No further Ebola cases in Uganda after June deaths - DR Congo  EWN
  3. Merck's Ebola vaccine helps combat deadly outbreak in the Congo as the virus spreads  CNBC
  4. Experimental Ebola Treatments Look Successful in Lab Studies, Says the CDC  TIME
  5. It’s time to declare a public health emergency on Ebola  The Washington Post
  6. View full coverage on Google News
Uganda says there have been no further cases of Ebola on its territory resulting from the deaths of two Ugandans who had travelled to DR Congo, the Congolese authorities said Wednesday. In an update on the epidemic in eastern Democratic Republic of Congo, the health ministry said its Ugandan counterparts had confirmed there had been no further […]

No Further Ebola Cases In Uganda After June Deaths: DR Congo - iAfrica.com

An unlicensed vaccine made by Merck was approved for use a week after the DRC declared the Ebola outbreak in August.An unlicensed vaccine made by Merck was approved for use a week after the DRC declared the Ebola outbreak in August.

Two therapies, the antiviral remdesivir and antibodies included in ZMapp, could work as treatments for Ebola in the Congo, the CDC says.An experimental vaccine also seems effective

Two Ebola Treatments Show Promise, CDC Says | Time

Health workers are using a new kind of isolation unit to treat Ebola patients. Called "the CUBE," the transparent walls of the room allow for more interaction between doctors and patients — and family members.Health workers are using a new kind of isolation unit to treat Ebola patients. Called "the CUBE," the transparent walls of the room allow for more interaction between doctors and patients — and family members.

In DR Congo, health workers pioneer new Ebola isolation 'CUBE'

Congo is facing the second worst outbreak in history. It’s time the WHO and the United States to step up.Congo is facing the second worst outbreak in history. It’s time the WHO and the United States to step up.

It’s time to declare a public health emergency on Ebola - The Washington Post

“ICYMI: @CDCgov scientists didn't have virus isolates from the North Kivu #Ebola outbreak, so they used genetic sequence to build one from scratch to test diagnostics, therapeutics. Pretty cool. https://t.co/VzGWSmwQdA”

Helen Branswell on Twitter: "ICYMI: @CDCgov scientists didn't have virus isolates from the North Kivu #Ebola outbreak, so they used genetic sequence to build one from scratch to test diagnostics, therapeutics. Pretty cool. https://t.co/VzGWSmwQdA"

“Nice deep dive here: Merck's Ebola vaccine helps combat deadly outbreak in the Congo as the virus spreads https://t.co/cpdrQ0C4Qp”

Dawn Kopecki on Twitter: "Nice deep dive here: Merck's Ebola vaccine helps combat deadly outbreak in the Congo as the virus spreads https://t.co/cpdrQ0C4Qp"

In an update on the epidemic in eastern DRC, the health ministry said its Ugandan counterparts had confirmed there had been no further infections. In an update on the epidemic in eastern DRC, the health ministry said its Ugandan counterparts had confirmed there had been no further infections.

No further Ebola cases in Uganda after June deaths - DR Congo

The U.S. Centers for Disease Control and Prevention published research in the journal Lancet Infectious Diseases outlining the results from two experimental Ebola drugs, Gilead Sciences’ remdesivir and Mapp Biopharmaceutical’s ZMapp. Both successfully inhibited the growth of the virus in human cells in laboratory studies.The U.S. Centers for Disease Control and Prevention published research in the journal Lancet Infectious Diseases outlining the results from two experimental Ebola drugs, Gilead Sciences’ remdesivir and Mapp Biopharmaceutical’s ZMapp. Both successfully inhibited the growth of the virus in human cells in laboratory studies.

Two Experimental Drugs Show Promise in Inhibiting Ebola Virus | BioSpace

CDC reverse-engineers the virus for important trials of interventions.CDC reverse-engineers the virus for important trials of interventions.

CDC's adapted Ebola virus works in trials, as pressure for funds grows | CIDRAP

ebolaebola

Congolese say Ebola is invented poison

The results are encouraging, but also raise questions about why outside research groups have not received direct access to viral specimens from the DRC.The results are encouraging, but also raise questions about why outside research groups have not received direct access to viral specimens from the DRC.

CDC made a synthetic Ebola virus to test treatments. It worked

WHO responders are braving bullets to end the outbreak in the Democratic Republic of the Congo, but the virus could cross borders without the pledged funding.WHO responders are braving bullets to end the outbreak in the Democratic Republic of the Congo, but the virus could cross borders without the pledged funding.

To contain Ebola, the United States must fulfil its promise to the World Health Organization